Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)

NCT04979130 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Chronic Inflammation
Intestinal Permeability

Interventions

DRUG: Semaglutide
DRUG: Placebo

Sponsor

University of Colorado, Denver

Collaborators

[object Object]